Back to Journals » International Journal of Nanomedicine » Volume 12

Biosensing of DNA oxidative damage: a model of using glucose meter for non-glucose biomarker detection

Authors Zhu X, Sarwar M, Yue Q, Chen C, Li CZ

Received 22 October 2016

Accepted for publication 2 December 2016

Published 2 February 2017 Volume 2017:12 Pages 979—987


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Thomas Webster

Xuena Zhu,1 Mehenur Sarwar,1 Qiaoli Yue,2 Chunying Chen,3 Chen-Zhong Li1,4

1Nanobioengineering/Bioelectronics Laboratory, Department of Biomedical Engineering, Florida International University, Miami, FL, USA; 2Department of Chemistry, College of Chemistry and Chemical Engineering, Liao Chen University, Shandong, 3CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, 4Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi’an, People’s Republic of China

Abstract: Non-glucose biomarker-DNA oxidative damage biomarker 8-hydroxy-2'-deoxyguanosine (8-OHdG) has been successfully detected using a smartphone-enabled glucose meter. Through a series of immune reactions and enzymatic reactions on a solid lateral flow platform, 8-OHdG concentration has been converted to a relative amount of glucose, and therefore can be detected by conventional glucose meter directly. The device was able to detect 8-OHdG concentrations in phosphate buffer saline as low as 1.73 ng mL-1 with a dynamic range of 1–200 ng mL-1. Considering the inherent advantages of the personal glucose meter, the demonstration of this device, therefore, should provide new opportunities for the monitoring of a wide range of biomarkers and various target analytes in connection with different molecular recognition events.

Keywords: 8-OHdG, immunostrip, point-of-care, POCTs, biosensor, DNA oxidative damage

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]